These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3961741)

  • 1. The effect of antithrombotics in a new model of arterial thrombosis.
    Hladovec J
    Thromb Res; 1986 Mar; 41(5):665-70. PubMed ID: 3961741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotics in view of thrombosis models.
    Hladovec J
    Thromb Res; 1986 Sep; 43(5):545-61. PubMed ID: 2944244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic drugs and experimental thrombosis.
    Hladovec J
    Cor Vasa; 1972; 20(2):135-41. PubMed ID: 4499917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitive model of venous thrombosis in rats.
    Hladovec J
    Thromb Res; 1986 Sep; 43(5):539-44. PubMed ID: 2944243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of different hirudins and combinations of low doses of hirudin, heparin and acetylsalicylic acid in a rat microcirculatory thrombosis model.
    Krupinski K; Breddin HK
    Haemostasis; 1991; 21 Suppl 1():88-92. PubMed ID: 1894199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of antithrombotic effect of aspirin by metoclopramide in rats.
    Mobarok Ali AT; al-Humayyd MS
    Thromb Res; 1991 Feb; 61(4):361-7. PubMed ID: 1648276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of troxerutin on laser-induced thrombus formation in rat mesenteric vessels, coagulation parameters and platelet function.
    Krupiński K; Giedrojć J; Bielawiec M
    Pol J Pharmacol; 1996; 48(3):335-9. PubMed ID: 9112673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combinations of a prostacyclin analogue (Cicaprost) with different antithrombotic agents in a rat microcirculatory thrombosis model.
    Giedrojc J; Breddin HK
    Int J Microcirc Clin Exp; 1992 Aug; 11(3):277-86. PubMed ID: 1324230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between the sulfated lactobionic acid (LW 10082) and other antithrombotic agents in animal thrombosis model.
    Giedrojć J; Krupiński K; Breddin HK; Bielawiec M
    Pol J Pharmacol; 1996; 48(3):317-22. PubMed ID: 9112669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic activity of Z4A5, a new platelet glycoprotein IIb/IIIa receptor antagonist evaluated in a rabbit arteriovenous shunt thrombosis model.
    Jing BB; Li YX; Zhang H; Ren ST; Wang M; Li YP; Zang WJ; Wang B
    Thromb Res; 2011 Nov; 128(5):463-9. PubMed ID: 21924458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental thrombosis model induced by free radicals. Application to aspirin and other different substances.
    Jourdan A; Aguejouf O; Imbault P; Doutremepuich F; Inamo J; Doutremepuich C
    Thromb Res; 1995 Jul; 79(1):109-23. PubMed ID: 7495098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic activity of a glycosaminoglycan (sulodexide) in rats.
    Andriuoli G; Mastacchi R; Barbanti M
    Thromb Res; 1984 Apr; 34(1):81-6. PubMed ID: 6729771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of some antithrombotic drugs on experimental arterial thrombosis.
    Hladovec J
    Cor Vasa; 1975; 17(1):66-74. PubMed ID: 1149460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic effects of some flavonoids alone and combined with acetylsalicylic acid.
    Hladovec J
    Arzneimittelforschung; 1977; 27(10):1989-92. PubMed ID: 579108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrinolytic complexes of low-molecular heparin and acetylsalicylic acid].
    Kudriashov BA; Pastorova VE; Liapina LA; Kondashevskaia MV
    Biull Eksp Biol Med; 1992 Jul; 114(8):141-3. PubMed ID: 1334726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial antithrombotic effects of aspirin, heparin, enoxaparin and clopidogrel alone, or in combination, in the rat.
    Daykin HJ; Sturgeon SA; Jones C; Wright CE
    Thromb Res; 2006; 118(6):755-62. PubMed ID: 16410020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulant and antithrombotic effects of combinations of defibrotide with heparins and other antithrombotic agents in an animal thrombosis model.
    Giedrojc J; Breddin HK
    Thromb Res; 1991 Jul; 63(1):99-110. PubMed ID: 1948825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic drugs in vascular medicine: a historical perspective.
    Schrör K
    Semin Vasc Med; 2003 May; 3(2):97-105. PubMed ID: 15199472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability of antithrombotics use in patients with hypoplastic left heart syndrome and its variants following first- and second-stage palliation surgery: a national report using the National Pediatric Cardiology Quality Improvement Collaborative registry.
    Ramachandran P; King E; Nebbia A; Beekman RH; Anderson JB
    Cardiol Young; 2017 May; 27(4):731-738. PubMed ID: 27981915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrageenin-induced thrombosis in rats and mice: a model for testing antithrombotic substances?
    Bekemeier H; Hirschelmann R; Giessler AJ
    Agents Actions; 1985 Jul; 16(5):446-51. PubMed ID: 4050621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.